Lyka Labs has received the product permission from the Central Drugs Standard Control Organization of India (CDSCO) to Manufacture and Market Tofacitinib Ointment 2% w/w. The company has received this permission after successfully completing the Clinical Trial on 125 patients across 8 Clinical Trial Centers within India.
Lyka Labs is engaged in the manufacture of pharmaceutical products. It also manufactures Veterinary products including injections, powders, creams and suspensions. The company offers various surgical disposables, such as syringes, surgical blades, cotton crepe bandage and first aid kits.
